348640-11-9 Usage
General Description
3-Bromo-5-Methoxyindole-1-Carboxylic Acid Tert-Butyl Ester is a chemical compound that belongs to the class of organic compounds known as indoles. It is a tert-butyl ester of 3-bromo-5-methoxyindole-1-carboxylic acid, which is a carboxylic acid derivative obtained by the formal condensation of the carboxy group of 3-bromo-5-methoxyindole-1-carboxylic acid with tert-butanol. It is a white to light brown powder with a molecular formula of C15H16BrNO3 and a molecular weight of 336.197 g/mol. 3-BROMO-5-METHOXYINDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used in chemical research and synthesis processes and may have potential pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 348640-11-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,8,6,4 and 0 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 348640-11:
(8*3)+(7*4)+(6*8)+(5*6)+(4*4)+(3*0)+(2*1)+(1*1)=149
149 % 10 = 9
So 348640-11-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H16BrNO3/c1-14(2,3)19-13(17)16-8-11(15)10-7-9(18-4)5-6-12(10)16/h5-8H,1-4H3
348640-11-9Relevant articles and documents
Azaindoles
-
Page/Page column 108, (2008/06/13)
The invention is directed to compositions containing physiologically active compounds of general formula (I): wherein R1 is aryl or heteroaryl; R2 represents hydrogen, acyl, cyano, halo, lower alkenyl or lower alkyl optionally substituted by a substituent selected from cyano, heteroaryl, heterocycloalkyl, —Z1R8, —C(═O)—NY3Y4, —CO2R8, —NY3Y4, —N(R6)—C(═O)—R7, —N(R6)—C(═O)—NY3Y4, —N(R6)—C(═O)—OR7, —N(R6)—SO2—R7, —N(R6)—SO2—NY3Y4 and one or more halogen a toms ; R3 represents hydrogen, aryl, cyano, halo, heteroaryl, lower alkyl, —C(═O)—OR5 or —C(═O)—NY3Y; and X1 represents N, CH, C-halo, C—CN, C—R7, C—NY3Y4, C—OH, C—Z2R7, C—C(═O)—OR5, C—C(═O)—NY3Y4, C—N(R8)—C(═O)—R7, C—SO2—NY3Y4, C—N(R8)—SO2—R7, C-alkenyl, C-alkynyl or C—NO2; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.